Location: Home
  • search
  • go
  • Relate News
  • 4/17/2025Akeso Advances Second ADC into Clinical Trials with TROP2/Nectin-4 Bis...
  • 4/17/2025Sanofi Secures Global Rights to AI-Discovered BsAb in $1.8B+ Deal with...
  • 4/17/2025Hengrui Advances CD79b-Targeted ADC SHR-A1912 into Phase 3 Trial for R...
  • 4/17/2025Latticon Pioneers China's First Pipeline-Backed Financing Deal
  • 4/17/2025Eddingpharm to Take Over Genor in HKEX's First 18A Reverse Merger
  • 4/17/2025WuXi AppTec Cashes Out of WuXi XDC as U.S. Tariff Threats Mount
  • 4/17/2025Pharma Giants Already Moving to Cut Reliance on China Amid Tariff Unce...
  • 4/15/2025Gardasil9 Gains Expanded Approval in China
  • 4/15/2025China NMPA Approves Kowa's Parmodia (Pemafibrate) for Dyslipidemia Tre...
  • 4/15/2025Chinese Pharma Companies Rethink Global Strategies as US Considers Dru...
  • 4/15/2025U.S. Tariff Threat on Chinese Pharma Could Reshape Landscape for India...
  • 4/15/2025Akeso Initiates First Clinical Trial for AK139, Its First Non-Oncology...
  • 4/15/2025Off-Label Drug Use in China After the Physician Law (2021): Legal Chal...
  • 4/14/2025Trump vs China Biotech: Who Will Emerge Victorious in the Tariff Trade...
  • 4/14/2025China's Online Pharmacy Market Surpasses CNY 70B: WMs Gain Ground as D...
  • 4/14/2025Sirius Receives FDA IND Clearance for FIC siRNA Therapy SRSD216 Target...
  • 4/14/2025iRegene Advances Chemically-Induced iPSC Platform, Pioneers Cell Thera...
  • 4/14/2025Belief BioMed/Takeda's hemophilia B Gene Therapy BBM-H901 Approved in...
  • 4/11/2025China Greenlights First Gene Therapy for Hemophilia B
  • 4/11/2025YiChang HEC ChangJiang Privatization Advances with NDRC Approval, Fina...
  • 4/11/2025Eli Lilly Seeks Approval for Novel Breast Cancer Drug in China, Target...
  • 4/11/2025Recent Executive Moves
  • 4/10/2025ArkBio Completes Phase 3 Trial for AK0901 for ADHD in China 
  • 4/10/2025Simcere's Anti-Tumor Candidate SIM0686 Gains Clinical Trial Approval i...
  • 4/10/2025Trump's Planned Tariffs on Imported Pharmaceuticals Target China
  • 4/10/2025China Unveils Ambitious Plan to Boost Health-Related Consumption
  • 4/10/2025Sumitomo Pharma Transfers Asian/Chinese Operations Amid Industry-Wide ...
  • 4/10/2025Novartis Files for New Indication of Long-Acting Cholesterol-Lowering ...
  • 4/10/2025XellSmart's XS411 Receives IND Clearance in China for Parkinson's Dise...
  • 4/10/2025NHC Ministers Meet with Top Pharma MNC Executives
  • Page:11/771 Total number of articles:23109: [First][<<] [9] [10] [11] [12] [13] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group